Introducing “What Just Happened?” with Christine Russo

Join Christine Russo, a leading industry analyst, in her discussions with leaders in retail, technology, innovation, metaverse and more.

 

Getting consumers to stay means providing quality product and quality rewards. Andrew Forman, CEO and Founder of Givz.com, a donation-driven marketing tool, sits down with host Christine Russo to discuss the story behind Givz and how his product is shaping the retail and ecommerce market.

There are current trends in retail.

  1. Brands are moving away from discounts but need to find a way to continue driving sales
  2. Consumers are demanding purpose-driven activity specific to each individual shopper

To meet those trends, Forman said, “Givz sits at the nexus of those two trends, allowing brands to convert discounts into donations and run what we’re calling donation-based incentives.”

Givz works by allowing the retailer to book the full amount of revenue while providing incentive post-purchase. “When you give a 20% discount, you’re losing 20% of your revenue. In this case, you’re getting the full amount of revenue,” said Forman. After purchasing, the customer can choose their charity of choice and donate to that charity through their purchase.

“The brand only pays for the people that actually follow through and go through with choosing their charity,” he continued.

The donation code itself is only valid for 14 days but customers do receive two reminder emails, once within 24 hours and once after 10 days, to use their code. With over 250,000 different charities, Givz has a plethora of charities to choose from and their impact is undeniable.

Over the course of Black Friday Weekend in 2021, “$60,000 went to real charities here in the United States, over 600 charities were supported,” stated Forman.

Givz works with companies such as H&M, Tervis, and Smile Direct Club and avoids decreasing conversion by using drop-down banners and PDP inserts through their Shopify app.

Brands can also use Givz through implementing an API I-frame on the web page or simply by sending an email.

More Stories Like This:

IBM Study Shows a Growing Portion of Consumers Embrace Hybrid Shopping

$40 Million in Funding Allows HugePOD to expand to the US

Follow us on social media for the latest updates in B2B!

Image

Latest

AI in marketing
From Queries to Conversations with AI in Marketing Analytics
April 21, 2025

In this episode of the SparkCast, Aby Varma—founder of Spark Novus, a firm that helps marketing leaders adopt AI responsibly and strategically—sits down with Daniel Kravtsov, CEO and Co-Founder of Improvado. Daniel shares his unique journey from Russia to founding a cutting-edge martech company in the Bay Area. Together, they explore how AI agents…

Read More
ESA
ESA Success Requires Strategy, Infrastructure, and Support Beyond Legislation
April 21, 2025

As education savings accounts (ESAs) gain traction across the United States, the conversation is shifting from policy debates to the complexities of implementation. Fueled by post-pandemic dissatisfaction with traditional school models and a desire for more customizable educational options, ESAs are being adopted in a growing number of states, often under “universal” frameworks. But…

Read More
supply chain data analytics
Supply Chain Data Analytics Fails Without Clean Data, Ventagium Delivers the Fix
April 21, 2025

Supply chain leaders face an overwhelming volume of siloed data across ERPs, TMS platforms, and warehouse systems, yet few know how to align it for smarter decisions. The stakes are rising fast. According to Capgemini’s 2024 report Data: A Powerful Ally in Tackling Scope 3 Emission Reduction Targets, 85% of organizations cite data access…

Read More
cancer immunotherapy
What’s Next in Preclinical Cancer Immunotherapy Research?
April 19, 2025

As the field of cancer immunotherapy rapidly evolves, researchers are turning to next-generation in vitro technologies to replicate the complexities of the tumor microenvironment with unprecedented fidelity. Organoid platforms and ex vivo patient-derived tissue models are transforming how scientists approach preclinical testing, offering deeper mechanistic insights and better predictive power for therapeutic response. With immunotherapies…

Read More